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METHODOLOGY Open Access
Pharmacology of reflex blinks in the rat:
a novel model for headache research
M. G. Jones1,5*, A. P. Andreou2,3, S. B. McMahon1 and D. Spanswick4
Abstract
Background: Migraineurs are highly sensitive to the nitric oxide donor glyceryl trinitrate which triggers attacks in
many sufferers. In animal studies, glyceryl trinitrate increases neuronal activity in the trigeminovascular pathway and
elevates neurotransmitter levels in the brainstem. Many migraineurs also display alterations in blink reflexes, known
to involve brainstem circuits. We investigated the effect of GTN on evoked blinks in the anaesthetised rat to
determine whether such reflexes may prove useful as the basis for a novel animal model to evaluate potential
anti-migraine therapeutic agents.
Method: In anaesthetised rats the electromyogram associated with the reflex blink evoked by corneal airpuff was
recorded. Rats were infused with glyceryl trinitrate, sumatriptan plus glyceryl trinitrate or vehicle control. Changes in
the magnitude of the reflex blink-associated electromyogram following these treatments were measured.
Results: Glyceryl trinitrate potentiated the evoked reflex blink-associated EMG response from 2 h after infusion. That
effect was abolished by simultaneous infusion of sumatriptan with glyceryl trinitrate.
Conclusions: These results show that simple skin surface measurements of evoked electromyographic activity in
the rat can reliably detect the evoked blink reflex that can be potentiated by nitric oxide donors. This novel model
may be an effective tool for evaluating putative anti-migraine therapeutic agents.
Keywords: Migraine, Blink reflex, Nitric oxide donor, Sumatriptan
Background
Migraine is a common and complex syndrome of the
nervous system [21]. Although its pathogenesis remains
unknown, it probably involves a cascade of events that
include both the central and the peripheral nervous sys-
tem. The trigeminal system appears to play an important
role in the manifestation of head pain and trigeminovas-
cular activation [22]. Centrally, the involvement of
diencephalic and brainstem mechanisms that modulate
the ascending trigeminal pathway is proposed by a num-
ber of clinical and pre-clinical studies to play, at least
partially, some role during migraine attacks [1, 2, 4].
Modelling the activation of the trigeminal system and
central brainstem alterations in animal models, has so
far involved mainly invasive procedures and either single
neuron electrophysiology or immunolabelling techniques
[7]. Glyceryl trinitrate (GTN) infusion, which in migrai-
neurs can induce a headache developing over the course
of hours into full migraine [12, 42], has been also
employed as a migraine model [8, 33]. In animal studies,
using invasive procedures, GTN has been shown to in-
crease neuronal activity of the trigeminovascular path-
way and elevate neurotransmitter levels in the brainstem
[20, 36, 38–40]. Peripherally, GTN has been shown to
influence the expression of calcitonin gene-related pep-
tide (CGRP) in the trigeminal ganglia, and more re-
cently, to reveal a number of transcriptional changes
[24]. Peripheral investigations in this model also in-
cluded the actions of triptans on nitric oxide-induced
dural vasodilatation [5]. Non-invasively, the GTN model
has been used to study behavioral endpoints with poten-
tial clinical relevance in migraine, such as photophobia,
facial expressions of pain and limb allodynia [11, 23].
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However, these endpoints can be subjective and multiple
GTN infusions may be required to reach a statistically
significant change.
In humans a subtle method for recording activation of
the trigeminal pathway and of brainstem mechanisms, is
that of the blink reflex. The blink reflex has been used
by a number of studies in humans to study brainstem
connectivity with the trigeminal system [19, 29, 44].
Although the actual measurements are of an electro-
myographic activity, the blink reflex is an objective
neurophysiological method that evaluates the connect-
ivity of the lateral medulla and pons with the trigeminal
and facial nerves. It involves stimulation of the ipsilateral
supraorbital branch of the trigeminal nerve which results
in an afferent response along the trigeminal nerve to the
trigeminal nucleus in the pons and the nucleus of the
spinal tract of the trigeminal nerve in the brainstem.
Through a series of interneurons in the pons and lateral
medulla, the nerve impulse next reaches the ipsilateral
and contralateral facial nuclei, from which the efferent
signal travels along the facial nerve bilaterally. The re-
sultant electropmyographic activity will have an R1 and
a delayed R2 component representing these oligo- and
poly-synaptic pathways in the brainstem between the
sensory trigeminal nucleus and the motor facial nucleus
[13, 18]. In migraine patients, a number of studies sug-
gested altered responses during and outside a migraine
attack [9, 15, 46], although the affected components dif-
fer in some of these reports. Increased blink reflex re-
sponses in the interictal phase and during migraine
attacks have been recorded [27, 28]. Studies investigating
the habituation phenomenon have shown reduced blink
reflex habituation responses during the premonitory
stages of migraine attacks [14, 16], that in the majority
of patients, normalise during a migraine attack [27].
More interestingly, GTN infusion in healthy volunteers
is shown to induce comparable changes in nociceptive
blink reflex, to those found immediately before and dur-
ing an attack in migraineurs [17]. These reports, not
only suggest the usefulness of the study of the blink re-
flex as a subtle neurophysiological outcome on central
brainstem changes that occur in migraine patients, but
also, the potential modelling of these changes with the
infusion of GTN.
Methods
Aim
In rodents, the blink reflex can be elicited by electrical
stimulation of the supraorbital nerve or by electrical or
physical stimulation of the corneal surface and/or palpe-
bral areas. In this study we aimed to investigate the blink
reflex in rodents during GTN infusion, an established
model of migraine, and to determine whether such re-
flexes may prove useful as the basis for a novel non-
invasive animal model to evaluate potential anti-
migraine therapeutic agents.
All experimental procedures were carried out at King’s
College London in accordance with UK Home Office
guidelines for the use of animals in experimental proce-
dures and with approval of the local ethical committee
at King’s College London.
Animals
Male Sprague-Dawley rats (300–375 g) were housed in
groups of three under controlled conditions on a 12 h
light-dark cycle, with ad libitum access to food and
water. A total of 31 animals were used in the study. Of
these animals 23 provided data that was considered
suitable for entry into the study. Data from the
remaining 8 animals was not entered. In all cases where
data was not entered into the study the reason was that
baseline recordings were not considered to be suffi-
ciently stable and reproducible measurements of EMG
could not be obtained.
In preparation for recording, animals were brought
from the holding facility to the laboratory on the day of
experiment, weighed and anaesthetised with urethane
(1.25 g/kg i.p). This anaesthetic was chosen as it pro-
vides a stable level of anaesthesia for many hours after
initial induction with no need for supplemental dosing.
The trachea, and left femoral artery and vein were
cannulated to facilitate, respectively, maintenance of
clear airway; recording of systemic arterial blood pres-
sure; and intravenous administration of pharmacological
agents. Animals were placed on a homeothermic heating
blanket and the core temperature monitored and kept at
37 ±1oC by means of feedback control system (Harvard
Apparatus, UK). No securing framework or support was
necessary to maintain the position of the animal during
the experiment. Animals were allowed to ventilate spon-
taneously with room air.
Electromyographic (EMG) Recordings
Electrodes for recording electromyographic (EMG) ac-
tivity consisted of teflon-coated silver wires melted to
form a ball at the tip. The fur over the left upper eyelid
was gently clipped close to the skin using fine scissors
and with the aid of a surgical microscope and the silver
ball was arranged with a micromanipulator such that its
surface was pressed lightly onto the surface of the skin
of the eyelid, over the orbicularis oculi (OO) muscle.
Good electrical contact was facilitated by applying a
small amount of electrode gel (SignaGel, Parker
Laboratories, USA) between the skin and the silver
ball. An indifferent electrode was placed in a similar
fashion approximately 8–10 mm away, on the skin
near the midline of the skull.
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Air puff evoked blink reflex
Reflex blinks were evoked by brief air puffs directed onto
the surface of the cornea and the upper palpebral mar-
gin using a custom-built air jet apparatus engineered in
our laboratory. The jet nozzle was positioned 5–6 mm
from the surface of the cornea (Fig. 1) and a single puff
stimulus was delivered once every 15 min to minimise
sensitisation of the cornea due to repeat stimulation.
Where necessary, the cornea was kept moist throughout
the experiment by the occasional application of artifi-
cial tear fluid (Scope Ophthalmics, UK). Any excess
moisture that accumulated over the corneal surface
was gently wicked away prior to the application of a
puff stimulus. The EMG of the orbicularis oculi
muscle (OO-EMG) was amplified (x5k) and filtered
(bandpass 300–1000Hz) using Neurolog equipment
(Digitimer, UK). Examples of these EMG traces can
be seen in Figs. 2 and 3.
The response to each stimulus was monitored on a
storage oscilloscope (Gould, UK) and recorded with a
computer running Spike 2 software (CED, Cambridge,
UK). After 1 h of baseline recording, vehicle (0.9 % sa-
line), GTN (150 μg/kg) or GTN plus sumatriptan
(300 μg/kg) were infused over a period of 30 min. In all
cases the infusion volume was 2 ml/kg. Following the
start of drugs infusion, stimulation at the rate of 4 puffs
per hour was continued for 3 h.
Considerable variation between animals was observed
in the magnitude of evoked OO-EMG. For the purposes
of statistical comparison, responses were rectified off-
line and averaged in 1 h epochs. The magnitude (area
under curve of mean rectified EMG) of the combined
R1 + R2 OO-EMG response at each hour post-infusion
was compared to baseline for each animal.
Pharmacological agents
Glyceryl trinitrate solution for injection (Nitronal, 1 mg/
ml; Merck, UK) was obtained from Guy’s Hospital Phar-
macy and diluted appropriately in 0.9 % saline to give a
dose of 150 μg/kg in a volume of 2 ml/kg. Sumatriptan
succinate (Imitrex, 12 mg/ml, GSK, UK) was obtained
from Guy’s Hospital Pharmacy and diluted appropriately
in 0.9 % saline for a dose of 300 μg/kg in a volume of
2 ml/kg.
Statistical analysis
The effect of treatment and time was examined by using
two-way analysis of variance (ANOVA) to compare all
treatment groups and all time points. More targeted
tests were performed using one-way ANOVA with
Bonferroni’s post hoc test for multiple comparisons.
P values of less than 0.05 were considered to be significant.
Results
All values for OO-EMG are expressed in arbitrary units
(V.sec) or as percentage changes from baseline for the
treatment groups at different time points. Mean values
are accompanied by standard error of the mean. Two-
way ANOVA of all raw data from each time point in the
three treatment groups indicated a highly significant ef-
fect of treatment (P < 0.05; F2,80 = 1.98). Representative
examples of traces from each time point in all treatment
groups are shown in Fig. 3.
1. Infusion of vehicle does not alter the magnitude of
the EMG
Vehicle (0.9 % saline) was administered in 7 rats. As
seen in the example in Fig. 2, there were no significant
Fig. 1 Schematic showing position of air puffer and recording electrodes with a simplified representation of the neural pathway involved in R1
and R2 components of the blink reflex. Afferent signals from sensory fibres innervating the cornea and the skin at the palpebral margin travel via
the supraorbital nerve (1st division of trigeminal nerve) and trigeminal ganglion to the brainstem. Efferent signals generating the blink response
travel in fibres of the facial nerve (cranial VII) from its motor nucleus to the orbicularis oculi muscles
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changes in the magnitude of OO-EMG from baseline
(range 0.0079–0.0509 V.sec) at any time point up to 3 h
after the beginning of infusion (range at 3 h 0.0053–
0.0588 V.sec; P = 0.62, F3,18 = 0.61, one-way ANOVA).
The group percentage changes at these time points are
summarised in Table 1.
2. Infusion of GTN significantly amplifies the
magnitude of the EMG
The effect of GTN was tested in 10 rats. Comparison
of the raw data values indicated a significant overall ef-
fect of the treatment (P = 0.0034, F3,27 = 5.81, one-way
Fig. 2 EMG traces showing (top to bottom) consecutive responses to single brief air puff directed at the centre of the cornea/palpebral margin
at intervals of 15 min. The R1 and R2 components of the blink reflex are clearly demarcated and the variability in both components is illustrated
in this example. Arrows indicate time of air puff delivery; horizontal scale bar = 10 ms
Fig. 3 Raw EMG traces showing activity in the ipsilateral suprapalpebral orbicularis oculi muscle evoked by air puffs. Each trace represents a single
sweep recorded during each of the four 1 h epochs - baseline up to 3 h after the start of infusion. Following GTN infusion, there is a progressive
increase in the intensity of the reflex EMG response. Co-infusion of sumatriptan with GTN completely inhibits this effect. By comparison, the EMG
remains stable after saline infusion. Arrows indicate timing of stimulus; horizontal scale bar = 10 ms
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ANOVA within group). Compared to baseline (range
0.0049–0.0398 V.sec) there was an increase of 42 ± 17 %
in the magnitude of the OO-EMG at 2 h after the
start of the 30 min infusion period (range 0.0049–
0.0463 V.sec), however this did not reach significance
(Table 1). At 3 h (range 0.0069–0.0469 V.sec), the increase
in response magnitude was significant at 55 ± 14 % of
baseline P < 0.05, t20 = 3.25; Table 1). At this time point,
the increase in the response was significantly greater than
in either the vehicle-treated group or the group in
which sumatriptan was co-infused with GTN (P < 0.005,
F2,20 = 7.86; one-way ANOVA between groups; Fig. 4).
3. Co-infusion of sumatriptan with GTN prevents the
GTN-evoked increase of the magnitude of the EMG
Co-infusion of GTN with sumatriptan was performed
in 6 rats. In this group there was no significant change
in the magnitude of the OO-EMG from baseline (range
0.0175–0.0618 V.sec) at any time point up to 3 h
post-infusion (range 0.0168–0.0398 V.sec; P = 0.73,
F3,15 = 0.44, one-way ANOVA within group), and this
was significantly different when compared to the re-
sponse of GTN alone (P < 0.05; F2,20 = 7.86; Fig. 4).
Discussion
Developing a non-invasive migraine animal model that
can reliably and easily demonstrate alterations of trigem-
inal and brainstem function has been a long unmet need
in the migraine research field. In this manuscript we
demonstrate that the blink reflex in the rat represents a
subtle and simple electrophysiological measurement to
detect altered activity of the trigeminal-brainstem reflex
in response to infusion of a nitric oxide donor. In our
model, corneal air puff reliably evoked the blink in the
anaesthetised rat and silver wire electrodes resting on
the skin surface provided a completely non-invasive
method of recording the reflex EMG activity from the
OO muscle.
Recording of the blink reflex is relatively simple meth-
odologically; requires a lesser degree of training for suc-
cessful implementation than, for example, single unit
recording; and could therefore potentially be adopted in
a wider number of laboratories. Use of air puff as a
stimulus in this study demonstrates that non-nociceptive
blink reflex activity evoked in this way can be stable over
a prolonged period and is susceptible to pharmacological
manipulation by agents known to impact neurotransmis-
sion in the trigeminocervical system.
NO donors such as GTN have been shown to trigger an
early onset headache and migraine attack in sufferers after
a delay of hours [26, 42]. In healthy subjects, a milder
early-onset headache is reported [43], which is also associ-
ated with decreased thresholds to mechanical nociceptive
stimuli [41]. Olesen and Ashina [32] suggest that normal
individuals may develop a migraine-like attack given ex-
posure to sufficient environmental and chemical stimuli.
Hence, the infusion of relatively higher doses of GTN in
rodents has been used as an animal model of migraine [8].
Table 1 Summary of changes in magnitude of OO-EMG response
in different treatment groups at different time points
Treatment Percent change from baseline post-treatment
1 h 2 h 3 h
Saline (7) -5 ± 9 +20 ± 12 -2 ± 9
GTN (10) +7 ± 14 +42 ± 17 +55 ± 14a
Sumatriptan + GTN (6) +11 ± 21 -5 ± 20 -5 ± 14
aDenotes significant difference with respect to GTN
Fig. 4 Histogram comparing the effects of vehicle, GTN and GTN plus sumatriptan on the magnitude of the evoked OO-EMG (combined R1 + R2
components) at 3 h post-infusion. Data were compared by one-way analysis of variance, with Bonferroni’s post-hoc test for multiple pairwise
comparisons (* P < 0.05). Bracketed values, n for each group. Inset: Examples of rectified OO-EMG recorded in rat receiving GTN infusion at baseline
(A) and at 3 h after infusion of GTN (B)
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A number of different techniques have been used in
the animal GTN infusion model for the detailed explor-
ation of the systems involved, and different end points
have been considered. By means of immunohistochemis-
try, expression of Fos, the protein product of the early
gene c-fos, has been widely used to study activation of
the systems involved. In rodents, systemic NO donors,
have been shown to induce Fos expression in the trige-
minocervical complex , brainstem and hypothalamus
[37, 39]. A limitation of the Fos marker however, is that
its expression in any tissue, after any stimulus peaks at
2–4 h [45] and incorrectly its presence in the TCC at
the 4 h time point has been thought to reflect the de-
layed onset of a migraine attack in humans. Although
immunohistochemistry is employed by many laborator-
ies, it has significant drawbacks. It is a time-consuming
and labour-intensive technique; the timing of observa-
tions must be carefully controlled; and no more than a
single trial is possible in each animal as sacrifice is ne-
cessary to obtain tissue for analysis. Our dose of GTN is
considerably smaller than the dose chosen in experi-
ments that administered GTN as an i.p. bolus injection
[38, 39] but is 2.5 fold higher than the dose selected by
Offenhauser et al. [31]in a study that failed to induce Fos
expression. We chose the intravenous route of administra-
tion in order to deliver GTN more effectively into the
circulation and used a dose of 150 μg/kg in an attempt to
maximise the chance of observing effects on blink reflex
recordings, whilst minimising cardiovascular effects.
Behavioural studies with GTN in animal models have
demonstrated a delayed occurrence of allodynia and
hyperalgesia in freely-moving animals, and photophobia
and facial expressions of pain have also been studied as
endpoints [11, 23]. However, recording of behavioural
endpoints can be highly subjective and many animals may
be required in order to see statistically significant change.
With our model we believe that there is less subjectivity in
the measurement of EMG responses and, importantly, we
were able to see highly significant results with relatively
small numbers of animals in each group. Therefore, our
model may also contribute, albeit in a modest way, to the
reduction of animal use.
Electrophysiological techniques have been infrequently
applied in conjunction with GTN administration in la-
boratory models. In a preliminary report, Akerman and
Goadsby [3] demonstrated that GTN infusion induced a
delayed increase of spontaneous and evoked firing of
second order neurons in the trigeminocervical complex,
by means of single neuron electrophysiology. The tech-
niques involved however, are highly invasive and require
a greater level of expertise than immunohistochemistry
[6]. Additionally, as neuronal sensitisation usually occurs
after 2–4 h of GTN infusion, such an approach requires a
greater effort in keeping stable single neuron recordings
for multiple hours and the data yield is correspondingly
low. In our model, we demonstrated that the blink reflex
EMG can be a reliable endpoint to record in the GTN in-
fusion model over several hours with no special measures
required to maintain mechanical stability. We have clearly
shown that GTN infusion significantly increased the amp-
litude of the blink reflex induced in response to corneal
air puff over time, likely reflecting sensitisation of trigemi-
nal centres in the brainstem. Interestingly, by measuring
blink reflexes in human subjects it has been shown that
GTN excites brainstem structures involved in migraine in
humans [17, 30]. Additionally, in a randomised double-
blind study measuring the nociceptive withdrawal reflex,
NO donors were shown to sensitise brainstem and trigem-
inal systems in migraine patients [34]. Hence, in our
model the use of the blink reflex enhancement as an end-
point following GTN infusion, represents a valid surrogate
for human migraine pathophysiology. It is worth investi-
gating in the future if other migraine provoking agents,
such as CGRP, could also influence the amplitude of the
blink reflex.
There are undoubtedly some limitations to this study.
We found that the R1 component was not always as
prominent as the R2 component and often showed con-
siderable variation over the course of multiple trials. Ac-
cordingly, the combined rectified activity of both R1 and
R2 was considered appropriate for analysis, as the R2
component is always much larger and this helped to
minimise natural variability. Notwithstanding the vari-
ability, we did not observe any consistent changes over
time (i.e. diminution of the response) that would suggest
habituation was occurring. Also, whilst other studies
have mainly focussed on the nociceptive blink reflex, in
this study we examined only the response to air puff,
which we consider to be a non-nociceptive stimulus.
Overall therefore, in this study it was difficult to explore
effects on each component of the reflex. The use of a
nociceptive stimulus, like cutaneous electrical stimula-
tion for example, that may permit more accurate meas-
urement of the R1 and R2 latencies, would add
additional information that could be recorded in our
model, and we do plan to pursue this in the future.
The experiments described here were performed in
anaesthetised rats as the blink reflex is preserved under
anaesthesia in humans and animals. However, the poten-
tial also exists for this model to be adapted for non-
anaesthetised animals. This would require subcutaneous,
chronically implanted and, ideally, telemetrically con-
nected electrodes; however, possible compromise of the
reflex by anaesthetic agents could thereby be avoided and
this is worth investigating in the future. Additionally, we
plan to investigate whether the blink reflex can be reliably
activated by other non-nociceptive vectors, such as fluid
droplets applied to the corneal surface, or photic stimuli.
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Headache induced by a nitric oxide donor in humans
responds to sumatriptan and thus can be used as a
model for the development of migraine drugs [25]. In
the GTN animal model, sumatriptan has been shown to
alleviate behavioural changes [10] and reduce Fos ex-
pression in the trigeminocervical complex [35]. In our
study we demonstrated that sumatriptan inhibits the po-
tentiation of reflex blinks following GTN infusion. Of
interest, zolmitriptan, was found to reverse blink reflex
changes observed during a migraine attack [15], suggest-
ing that our animal model of blink reflex could be used
to explore the efficacy of newer migraine drugs.
Conclusions
We have demonstrated that a simple method using silver
wire electrodes resting on the skin surface provides a re-
liable and completely non-invasive method of recording
EMG activity from the OO muscle in response to activa-
tion of the blink reflex. Recordings of the blink reflex
can provide an insight into the state of activation of tri-
geminal and brainstem structures involved in migraine
and in our study GTN infusion significantly potentiated
the intensity of air puff-evoked reflex blinks, an effect
that was blocked by sumatriptan. Our preparation may
prove a useful, novel and, importantly, translational elec-
trophysiological model for evaluation of candidate anti-
migraine compounds in the laboratory.
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